GlassScriptPhysician profile
Ankush Kumar Jain
NPI 1770891574
$26,253.62
in general payments reported to CMS, 2019-2025
24 companies · $3,864 in 2025
The $3,864 reported for 2025 was more than what 92% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,091 · 2020: $144 · 2021: $1,951 · 2022: $4,553 · 2023: $3,457 · 2024: $5,193 · 2025: $3,864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,513.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15,854.76 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $5,053.78 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $2,105.48 | 2019-2020 | |
| Nevro Corp. | $972.10 | 2019-2024 | Senza |
| Globus Medical, INC. | $652.18 | 2025 | Omnia, Senza |
| Collegium Pharmaceutical, INC. | $417.32 | 2020-2023 | Xtampza |
| Abbott Laboratories | $174.69 | 2023-2024 | Proclaim |
| Si-Bone, INC. | $161.67 | 2021-2025 | |
| Vertos Medical, INC. | $147.47 | 2024 | Mild Device Kit |
| Merz North America, INC. | $141.96 | 2019 | |
| Surgalign Spine Technologies, INC. | $103.21 | 2021 | |
| Nalu Medical, INC. | $79.24 | 2023-2024 | Nalu Neurostimulation System |
| Tersera Therapeutics LLC | $63.28 | 2022-2024 | Prialt |
| Biodelivery Sciences International, INC. | $49.55 | 2020-2021 | |
| Saluda Medical Americas, INC. | $47.80 | 2023 | Evoke Scs |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $40.16 | 2023-2025 | Dysport |
| Amgen INC. | $37.21 | 2025 | Evenity |
| Curonix LLC | $35.16 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $29.92 | 2022-2025 | Triluron, Hymovis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.22 | 2025 | Relistor, Trulance |
| Scilex Pharmaceuticals INC. | $17.59 | 2022 | |
| Redhill Biopharma INC. | $16.03 | 2021 | |
| Painteq LLC | $15.12 | 2023 | Painteq |
| Grt US Holding, INC. | $13.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankush Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.